Afficher la couverture 'Overcoming the Brain Barriers: From Immune Cells to Nanoparticles | Charabati, Marc' en grand format
/5

0 avis

Overcoming the Brain Barriers: From Immune Cells to Nanoparticles

Archive ouverte

Charabati, Marc | Rabanel, Jean-Michel | Ramassamy, Charles | Prat, Alexandre

Edité par CCSD ; Elsevier -

International audience. Nanoparticulate carriers, often referred to as nanoparticles (NPs), represent an important pharmacological advance for drug protection and tissue-specific drug delivery. Accessing the central nervous system (CNS), however, is a complex process regulated by mainly three brain barriers. While some leukocyte (i.e., immune cell) subsets are equipped with the adequate molecular machinery to infiltrate the CNS in physiological and/or pathological contexts, the successful delivery of NPs into the CNS remains hindered by the tightness of the brain barriers. Here, we present an overview of the three major brain barriers and the mechanisms allowing leukocytes to migrate across each of them. We subsequently review different immune-inspired and -mediated strategies to deliver NPs into the CNS. Finally, we discuss the prospect of exploiting leukocyte trafficking mechanisms for further progress.

Consulter en ligne

Suggestions

Du même auteur

Isolation of endothelial cells, pericytes and astrocytes from mouse brain

Archive ouverte | Bernard-Patrzynski, Florian | CCSD

International audience. Primary cell isolation from the central nervous system (CNS) has allowed fundamental understanding of blood-brain barrier (BBB) properties. However, poorly described isolation techniques or s...

Identification of SARS-CoV-2-specific immune alterations in acutely ill patients

Archive ouverte | Rebillard, Rose-Marie | CCSD

Dysregulated immune profiles have been described in symptomatic patients infected with SARS-CoV-2. Whether the reported immune alterations are specific to SARS-CoV-2 infection or also triggered by other acute illnesses remains unc...

Periphery-confined particulate systems for the management of neurodegenerative diseases and toxicity: Avoiding the blood-brain-barrier challenge

Archive ouverte | Rabanel, Jean-Michel | CCSD

International audience. The blood-brain barrier prevents passage of large and hydrophilic molecules, undermining efforts to deliver most active molecules, proteins and other macromolecules. To date, nanoparticle-ass...

Chargement des enrichissements...